Literature DB >> 25406732

Metabotropic P2Y1 receptor signalling mediates astrocytic hyperactivity in vivo in an Alzheimer's disease mouse model.

Andrea Delekate1, Martina Füchtemeier2, Toni Schumacher1, Cordula Ulbrich1, Marco Foddis3, Gabor C Petzold4.   

Abstract

Astrocytic network alterations have been reported in Alzheimer's disease (AD), but the underlying pathways have remained undefined. Here we measure astrocytic calcium, cerebral blood flow and amyloid-β plaques in vivo in a mouse model of AD using multiphoton microscopy. We find that astrocytic hyperactivity, consisting of single-cell transients and calcium waves, is most pronounced in reactive astrogliosis around plaques and is sometimes associated with local blood flow changes. We show that astroglial hyperactivity is reduced after P2 purinoreceptor blockade or nucleotide release through connexin hemichannels, but is augmented by increasing cortical ADP concentration. P2X receptor blockade has no effect, but inhibition of P2Y1 receptors, which are strongly expressed by reactive astrocytes surrounding plaques, completely normalizes astrocytic hyperactivity. Our data suggest that astroglial network dysfunction is mediated by purinergic signalling in reactive astrocytes, and that intervention aimed at P2Y1 receptors or hemichannel-mediated nucleotide release may help ameliorate network dysfunction in AD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25406732     DOI: 10.1038/ncomms6422

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  97 in total

1.  Astroglial connexin43 contributes to neuronal suffering in a mouse model of Alzheimer's disease.

Authors:  C Yi; X Mei; P Ezan; S Mato; I Matias; C Giaume; A Koulakoff
Journal:  Cell Death Differ       Date:  2016-07-08       Impact factor: 15.828

Review 2.  Medicinal chemistry of adenosine, P2Y and P2X receptors.

Authors:  Kenneth A Jacobson; Christa E Müller
Journal:  Neuropharmacology       Date:  2015-12-12       Impact factor: 5.250

3.  CREB decreases astrocytic excitability by modifying subcellular calcium fluxes via the sigma-1 receptor.

Authors:  A Eraso-Pichot; R Larramona-Arcas; E Vicario-Orri; R Villalonga; L Pardo; E Galea; R Masgrau
Journal:  Cell Mol Life Sci       Date:  2016-10-19       Impact factor: 9.261

Review 4.  Unravelling and Exploiting Astrocyte Dysfunction in Huntington's Disease.

Authors:  Baljit S Khakh; Vahri Beaumont; Roger Cachope; Ignacio Munoz-Sanjuan; Steven A Goldman; Rosemarie Grantyn
Journal:  Trends Neurosci       Date:  2017-05-31       Impact factor: 13.837

Review 5.  Purinergic receptors as potential therapeutic targets in Alzheimer's disease.

Authors:  Lucas T Woods; Deepa Ajit; Jean M Camden; Laurie Erb; Gary A Weisman
Journal:  Neuropharmacology       Date:  2015-10-28       Impact factor: 5.250

Review 6.  Astroglial Calcium Signaling in Aging and Alzheimer's Disease.

Authors:  Alexei Verkhratsky
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-07-01       Impact factor: 10.005

7.  Purinergic signaling triggers endfoot high-amplitude Ca2+ signals and causes inversion of neurovascular coupling after subarachnoid hemorrhage.

Authors:  Anthony C Pappas; Masayo Koide; George C Wellman
Journal:  J Cereb Blood Flow Metab       Date:  2016-05-20       Impact factor: 6.200

8.  Mechanism and consequence of abnormal calcium homeostasis in Rett syndrome astrocytes.

Authors:  Qiping Dong; Qing Liu; Ronghui Li; Anxin Wang; Qian Bu; Kuan Hong Wang; Qiang Chang
Journal:  Elife       Date:  2018-03-29       Impact factor: 8.140

9.  Neuron-astrocyte signaling is preserved in the aging brain.

Authors:  Marta Gómez-Gonzalo; Mario Martin-Fernandez; Ricardo Martínez-Murillo; Sara Mederos; Alicia Hernández-Vivanco; Stephanie Jamison; Ana P Fernandez; Julia Serrano; Pilar Calero; Hunter S Futch; Rubén Corpas; Coral Sanfeliu; Gertrudis Perea; Alfonso Araque
Journal:  Glia       Date:  2017-01-28       Impact factor: 7.452

Review 10.  Diversity of astrocyte functions and phenotypes in neural circuits.

Authors:  Baljit S Khakh; Michael V Sofroniew
Journal:  Nat Neurosci       Date:  2015-07       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.